Cutler Group LP Jaguar Health, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$1.03 - $2.48 $67 - $163
-66 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$2.14 - $4.95 $141 - $326
66 New
66 $0

Others Institutions Holding JAGX

# of Institutions
2
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Jaguar Health, Inc.

JAGX Quotes by TradingView
  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email